↓ Skip to main content

Cochrane Database of Systematic Reviews

Monoamine oxidase B inhibitors for early Parkinson's disease

Overview of attention for article published in Cochrane database of systematic reviews, July 2005
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (75th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

policy
1 policy source
twitter
1 tweeter
facebook
1 Facebook page

Citations

dimensions_citation
41 Dimensions

Readers on

mendeley
121 Mendeley
Title
Monoamine oxidase B inhibitors for early Parkinson's disease
Published in
Cochrane database of systematic reviews, July 2005
DOI 10.1002/14651858.cd004898.pub2
Pubmed ID
Authors

Kristian Turnbull, Robert Caslake, Angus Macleod, Natalie Ives, Rebecca Stowe, Carl Counsell

Abstract

It has been postulated that monoamine oxidase B (MAO-B) inhibitors alter disease progression in Parkinson's disease (PD). Clinical trials have produced conflicting results.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 121 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 <1%
Colombia 1 <1%
France 1 <1%
Unknown 118 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 20 17%
Student > Bachelor 19 16%
Researcher 12 10%
Student > Ph. D. Student 12 10%
Student > Doctoral Student 11 9%
Other 30 25%
Unknown 17 14%
Readers by discipline Count As %
Medicine and Dentistry 44 36%
Neuroscience 12 10%
Pharmacology, Toxicology and Pharmaceutical Science 10 8%
Nursing and Health Professions 8 7%
Agricultural and Biological Sciences 8 7%
Other 18 15%
Unknown 21 17%

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 March 2016.
All research outputs
#4,263,129
of 15,827,677 outputs
Outputs from Cochrane database of systematic reviews
#6,864
of 11,293 outputs
Outputs of similar age
#65,674
of 266,967 outputs
Outputs of similar age from Cochrane database of systematic reviews
#95
of 158 outputs
Altmetric has tracked 15,827,677 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 11,293 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 23.5. This one is in the 38th percentile – i.e., 38% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 266,967 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 158 others from the same source and published within six weeks on either side of this one. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.